PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
114.16%
Some net income increase while CRON.TO is negative at -999.96%. John Neff would see a short-term edge over the struggling competitor.
94.53%
D&A growth well above CRON.TO's 14.19%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
797.79%
Well above CRON.TO's 661.59% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
180.67%
SBC growth well above CRON.TO's 31.05%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-181.03%
Both reduce yoy usage, with CRON.TO at -109.36%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-1.41%
Both yoy AR lines negative, with CRON.TO at -38.93%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-432.56%
Negative yoy inventory while CRON.TO is 3.08%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
136819619187916704.00%
AP growth well above CRON.TO's 213.23%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-78.19%
Both reduce yoy usage, with CRON.TO at -299.01%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-206.43%
Negative yoy while CRON.TO is 99.03%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-96.29%
Both yoy CFO lines are negative, with CRON.TO at -87.37%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-174.60%
Both yoy lines negative, with CRON.TO at -16.32%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
65333.79%
Acquisition growth of 65333.79% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-596.55%
Negative yoy purchasing while CRON.TO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-65.46%
Both yoy lines are negative, with CRON.TO at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-52.52%
Both yoy lines negative, with CRON.TO at -620.10%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-869.69%
Both yoy lines negative, with CRON.TO at -21.25%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-30.32%
We cut debt repayment yoy while CRON.TO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.